# Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection - Phase II Clinical Trial

> clinical trial · VERIFIED · 2026-07-24

Status: ACTIVE_NOT_RECRUITING · Sponsor: Chang Gung Memorial Hospital · Condition: Hepatocellular Carcinoma

- Company: Chang Gung Memorial Hospital
- Sector: Hepatocellular Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT06193733

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.